Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Methicillin-resistant Staphylococcus Aureus Infection Clinical Trial

Official title:
A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers

Status Terminated

Clinical Trial Summary

The purpose of the study is to determine if topically applied nitric oxide gas is effective in reducing the quantity of bacteria (including MRSA)in a wound.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Methicillin-resistant Staphylococcus Aureus Infection
Skin Ulcer
Skin Ulcers
Staphylococcal Infections

Clinical Trial Details

NCT number	NCT00790608
Study type	Interventional
Source	Nitric BioTherapeutics, Inc
Contact
Status	Terminated
Phase	Phase 2
Start date	January 2009
Completion date	August 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01817075` - Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant	Phase 3
Completed	`NCT00822692` - Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection	N/A
Terminated	`NCT01028105` - Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections	N/A